Arcellx (ACLX) Operating Margin (2023 - 2025)

Arcellx (ACLX) recorded quarterly Operating Margin of 14356.29% in Q4 2025, up 1238.72% quarter-over-quarter from 1260.73% in Q3 2025, and up 1470446.0% on a YoY basis from N/an in Q4 2024.

Arcellx (ACLX) Operating Margin (2023 - 2025) Analysis & Trends

Arcellx's Operating Margin history runs 3 years deep, the most recent figure standing at 14356.29% for Q4 2025.

  • In Q4 2025, Operating Margin rose 1470446.0% year-over-year to 14356.29%; the TTM figure through Dec 2025 stood at 215.65% (up 34310.0% YoY), while the FY2025 annual figure was 215.62%, up 34308.0% from the prior year.
  • Operating Margin was 14356.29% for Q4 2025 at Arcellx, up from 1260.73% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 14356.29% in Q4 2025 to a low of 1260.73% in Q3 2025.
  • Historically, Operating Margin has averaged 848.08% across 3 years, with a median of 188.36% in 2023.
  • Biggest YoY gain for Operating Margin was 1470446 bps in 2025; the steepest drop was 113159 bps in 2025.
  • A 3-year view of Operating Margin shows it stood at 23.75% in 2023, then plunged by 1566 bps to 348.17% in 2024, then jumped by 4223 bps to 14356.29% in 2025.
  • The last three Operating Margin figures came in at 14356.29% (Q4 2025), 1260.73% (Q3 2025), and 772.71% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -6.43%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 38.10%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Arcellx 6.48 Bn 6.48 Bn - 14,356.29%

Historic Data

Download Data
DateValue
Dec 31, 2025 14,356.29%
Sep 30, 2025 -1,260.73%
Jun 30, 2025 -772.71%
Mar 31, 2025 -847.56%
Dec 31, 2024 -348.17%
Sep 30, 2024 -129.14%
Jun 30, 2024 -127.79%
Mar 31, 2024 -40.27%
Dec 31, 2023 23.75%
Sep 30, 2023 -299.94%
Jun 30, 2023 -206.68%
Mar 31, 2023 -170.04%